Since a consortium of hospital systems and the U.S. Department of Veterans Affairs formed their own not-for-profit drug company to make generic drugs that are in short supply or overpriced, an additional 100 hospitals have joined the initiative. Salt Lake City-based Intermountain Healthcare, which lead the initiative, believes up to 1,000 hospitals, or about 20% of all U.S. hospitals, will sign on. The healthcare systems expect to spend the next year developing the business and begin operations during the first quarter of 2019. The health systems intend to be selective about which generics they manufacture so as to focus on drugs that have high mark-ups. The goal is to enter long-term contracts with hospital systems. In its latest Generics 360 report, Canada's Patented Medicines Prices Review Board revealed that only the U.S. among OECD nations paid more per capita than Canada's $165.
NBHC Sustainability